Swiss National Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-164,957
| Closed | -$2.97M | – | 2439 |
|
|
2020
Q2 | $2.97M | Buy |
164,957
+21,600
| +15% | +$300K | ﹤0.01% | 1480 |
|
|
2020
Q1 | $1.02M | Buy |
143,357
+4,400
| +3% | +$54.9K | ﹤0.01% | 1812 |
|
|
2019
Q4 | $3.32M | Buy |
138,957
+3,200
| +2% | +$88.3K | ﹤0.01% | 1415 |
|
|
2019
Q3 | $3.64M | Buy |
135,757
+24,500
| +22% | +$688K | ﹤0.01% | 1287 |
|
|
2019
Q2 | $3.02M | Sell |
111,257
-3,800
| -3% | -$119K | ﹤0.01% | 1439 |
|
|
2019
Q1 | $3.99M | Buy |
115,057
+4,000
| +4% | +$115K | ﹤0.01% | 1232 |
|
|
2018
Q4 | $2.17M | Buy |
111,057
+3,100
| +3% | +$63.8K | ﹤0.01% | 1522 |
|
|
2018
Q3 | $2.88M | Hold |
107,957
| – | – | ﹤0.01% | 1477 |
|
|
2018
Q2 | $4.08M | Sell |
107,957
-5,800
| -5% | -$222K | ﹤0.01% | 1235 |
|
|
2018
Q1 | $3.71M | Buy |
113,757
+5,400
| +5% | +$237K | ﹤0.01% | 1235 |
|
|
2017
Q4 | $5.28M | Hold |
108,357
| – | – | 0.01% | 1020 |
|
|
2017
Q3 | $5.86M | Buy |
108,357
+15,300
| +16% | +$898K | 0.01% | 932 |
|
|
2017
Q2 | $5.23M | Hold |
93,057
| – | – | 0.01% | 965 |
|
|
2017
Q1 | $3.65M | Buy |
93,057
+3,100
| +3% | +$98.7K | ﹤0.01% | 1181 |
|
|
2016
Q4 | $2.02M | Hold |
89,957
| – | – | ﹤0.01% | 1549 |
|
|
2016
Q3 | $2.04M | Sell |
89,957
-2,100
| -2% | -$49.3K | ﹤0.01% | 1499 |
|
|
2016
Q2 | $2.17M | Hold |
92,057
| – | – | ﹤0.01% | 1454 |
|
|
2016
Q1 | $1.81M | Buy |
92,057
+21,757
| +31% | +$690K | ﹤0.01% | 1508 |
|
|
2015
Q4 | $3.62M | Buy |
70,300
+12,000
| +21% | +$582K | 0.01% | 962 |
|
|
2015
Q3 | $2.48M | Buy |
58,300
+7,800
| +15% | +$376K | 0.01% | 1164 |
|
|
2015
Q2 | $2.3M | Buy |
50,500
+800
| +2% | +$32.2K | 0.01% | 1219 |
|
|
2015
Q1 | $1.89M | Buy |
49,700
+12,300
| +33% | +$423K | 0.01% | 1332 |
|
|
2014
Q4 | $1.06M | Buy |
37,400
+6,100
| +19% | +$170K | ﹤0.01% | 1701 |
|
|
2014
Q3 | $791K | Hold |
31,300
| – | – | ﹤0.01% | 1809 |
|
|
2014
Q2 | $913K | Buy |
31,300
+5,800
| +23% | +$140K | ﹤0.01% | 1771 |
|
|
2014
Q1 | $660K | Buy |
25,500
+9,400
| +58% | +$251K | ﹤0.01% | 1972 |
|
|
2013
Q4 | $415K | Buy |
+16,100
| New | +$391K | ﹤0.01% | 2102 |
|
Swiss National Bank's PTLA Position: Q3 2020 in Review
Swiss National Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 164,957 shares — an estimated $2.97M sold.
Swiss National Bank first reported a position in PTLA in Q4 2013 and held it in 27 quarters. The position peaked at $5.86M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Swiss National Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Swiss National Bank sold 164,957 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.97M.
- Swiss National Bank first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 27 quarters.
- Swiss National Bank's Portola Pharmaceuticals, Inc. position peaked at $5.86M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Swiss National Bank's 13F filing for Q3 2020, filed 9 Nov 2020.